3rd Quarter - Report
HEALTH AND MEDICINE COUNSEL for PROLONG PHARMACEUTICALS LLC
Client
Income
$10,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Access to treatments for people with Sickle Cell Disease, treatment center model Sickle Cell Legislation Engaging NIH/CDC on hematology issues Research at NHLBI & NIDDK Cures Implementation & Patient Centered efforts
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANE CHRISTIANSEN | Legislative Consultant |
| DALE P DIRKS | Legislative Consultant |
| PHILIP GOGLAS | Legislative Consultant |
| JOSEPH STEWART | Legislative Consultant |
Budget/Appropriations BUD
FY17 & FY18 funding for Blood Disorders Programs, TBI & Transplantation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANE CHRISTIANSEN | Legislative Consultant |
| DALE P DIRKS | Legislative Consultant |
| PHILIP GOGLAS | Legislative Consultant |
| JOSEPH STEWART | Legislative Consultant |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.